The company operates a single trading segment that accounts for 100% of segment revenue for FY26. Segment revenue of ₹32.00 crore was reported from trading activities, while consolidated net profit for the year was ₹20.71 crore. The cost structure is unusual for a trading business, with zero materials cost, employee costs at 4.5% of revenue, other operating expenses at 8.1%, and depreciation at 2.1%, against a reported EBITDA margin of 67.21%. Segment EBIT was ₹0.26 crore, indicating that most of the company's profitability sits outside its reported trading segment. The Board has recommended a dividend of ₹3.50 per equity share (175% on face value of ₹2) for FY26, up from ₹0.50 per share in FY25. Demuric Holdings Private Limited, a promoter group member, acquired 73.28% of paid-up capital in July 2026 through an internal reorganization of promoter entities. AR · MarketPing reader · 2026-08-02
Revenue streams, as the annual report describes them. TRADING (100%). Single-segment chemicals trading entity with very high reported EBITDA margin relative to thin segment EBIT
| ₹ crore · consolidated | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue | 1 | 1 | 51 | 112 | 32 |
| EBITDA (ex other income) | (3) | (3) | (3) | (4) | (4) |
| margin % | (255.9) | (194.5) | (6.1) | (3.4) | (11.6) |
| Owners' profit | 55 | 39 | 39 | 0 | 21 |
| EPS, as reported (₹) | 7.85 | 5.64 | 5.55 | 0.04 | 2.98 |
| ROE % · ROCE % | 1.7 · 1.6 | 1.3 · 1.3 | 1.9 · 1.9 | 0.0 · 0.1 | 0.8 · 0.8 |
| Debt / equity (x) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from operations | 1 | (1) | (3) | (3) | (3) |
| Capex | 0 | 0 | 0 | 0 | 0 |
| ₹ crore | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 30 | 5 | 73 | 6 | 0 | 0 | 26 | 0 |
| Profit before tax | 4 | (2) | (2) | (1) | 23 | (1) | (1) | (1) |
| Net profit | 4 | (2) | (2) | (1) | 23 | (1) | (1) | (1) |
| EPS (₹) | 0.56 | (0.27) | (0.23) | (0.11) | 3.33 | (0.15) | (0.10) | (0.17) |
| Company | M.cap ₹ cr | P/E | P/B | EV/EBITDA | ROE % | ROCE % | Rev CAGR 5y % | EBITDA m. % |
|---|---|---|---|---|---|---|---|---|
| UNIPHOS ENTERPRISES LTD ◆ | 635 | 31.4 | 0.26 | — | 0.8 | 0.8 | — | — |
| VINYL CHEMICALS (I) LTD. | 402 | 17.3 | 3.09 | — | 12.7 | 16.8 | — | 9.0 |
| EVEXIA LIFECARE LIMITED | 310 | 55.0 | 0.71 | 108.2 | 0.4 | 0.3 | 0.7 | 3.3 |
| BHAVIK ENTERPRISES LIMITED | 293 | 19.8 | — | — | — | 11.1 | — | — |
| Date · filing | Category | Importance | 1-day % | 5-day % |
|---|---|---|---|---|
| 8 Sept 2026 · Newspaper notice on SEBI special window for physical share transfer and demat | compliance | minimal | — | — |
| 14 Aug 2026 · Q1 FY27 Results: Revenue Rs 26.14 cr, Net Loss Rs 1.19 cr | compliance | minimal | — | — |
| 12 Aug 2026 · Uniphos Enterprises files Q1 FY27 unaudited results with auditor review | results | high | — | — |
| 7 Aug 2026 · 57th AGM: All 3 resolutions passed; dividend declared for FY26 | board shareholder meetings | low | — | — |
| 4 Aug 2026 · Board meeting on 12 Aug 2026 to consider Q1 FY27 results | results | low | — | — |
| 22 Jul 2026 · Demuric Holdings acquires 73.28% in Uniphos via internal group merger | ownership changes | medium | — | — |
| 17 Jul 2026 · Uniphos Enterprises: 57th AGM on Aug 7, 2026 via video conferencing | compliance | minimal | — | — |
| 16 Jul 2026 · Uniphos Enterprises 57th AGM on August 7, 2026; dividend of Rs 3.50 per share | board shareholder meetings | low | — | — |
| 6 Jul 2026 · RTA files quarterly dematerialisation compliance certificate for Q1 FY27 | compliance | minimal | — | — |
| 6 Jul 2026 · Copy of newspaper publication submitted to Exchange | compliance | minimal | — | — |
| Where a broker report shows | This document shows | Why |
|---|---|---|
| A rating (BUY / ADD / REDUCE / SELL) | A state: the latest filed quarter and the measured reactions |
| A-1 LIMITED |
| 289 |
| 26.2 |
| 5.34 |
| 26.2 |
| 11.1 |
| 14.8 |
| — |
| 3.5 |
| SHANKAR LAL RAMPAL LTD | 245 | 13.3 | 2.00 | — | 11.0 | 14.7 | — | 9.4 |
| MYSORE PETRO CHEMICALS L | 93 | 17.1 | 0.41 | 100.3 | 0.4 | 0.2 | 18.0 | (0.4) |
| Yash Chemex Limited | 53 | 24.1 | 0.87 | 14.4 | 4.0 | 5.2 | 20.6 | (0.0) |
| Metric | Company | Group median | Rank | Better than |
|---|---|---|---|---|
| P/E (TTM) | 31.4 | 17.2 | 13 of 14 | 8% |
| P/B | 0.3 | 0.8 | 1 of 10 | 100% |
| ROCE | 0.8 | 3.0 | 8 of 14 | 46% |
| ROE | 0.8 | 0.8 | 5 of 10 | 56% |
| Debt / Equity | 0.0 | 0.0 | 1 of 10 | 89% |
| Revenue growth | (100.0) | 10.9 | 11 of 11 | 0% |
| Profit growth | (61.6) | 5.7 | 7 of 10 | 33% |
| Market cap | 635 | 93 | 1 of 13 | 100% |
| an event is a fact; a rating is an opinion that requires SEBI RA registration |
| A target price and upside | The current price and the multiples against the group | a target is a forecast; a multiple is a measurement |
| Estimate years marked E | More audited years; no estimates | MarketPing publishes no forecasts — your own model lives on the Models page |
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.
